Genetic Variants in Cytosolic 5′-Nucleotidase II Are Associated with Its Expression and Cytarabine Sensitivity in HapMap Cell Lines and in Patients with Acute Myeloid Leukemia

Cytosolic 5′-nucleotidase II (NT5C2) is involved in the development of 1-β-d-arabinofuranosylcytosine (ara-C) resistance and has been associated with clinical outcome in patients receiving ara-C-based chemotherapy. NT5C2 inactivates ara-C by dephosphorylating ara-C monophosphate to ara-C. In this st...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Mitra, Amit K., Crews, Kristine R., Pounds, Stanley, Cao, Xueyuan, Feldberg, Tanya, Ghodke, Yogita, Gandhi, Varsha, Plunkett, William, Dolan, M. Eileen, Hartford, Christine, Raimondi, Susana, Campana, Dario, Downing, James, Rubnitz, Jeffrey E., Ribeiro, Raul C., Lamba, Jatinder K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The American Society for Pharmacology and Experimental Therapeutics 2011
Aiheet:
Metabolism, Transport, and Pharmacogenomics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186292/
https://ncbi.nlm.nih.gov/pubmed/21712425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.111.182873
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia